Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

shutter

Ovid’s Angelman syndrome therapy falls short at Phase 3

December 2, 2020 Research and Development Angelman syndrome, Ovid

Ovid Therapeutics has revealed disappointing results for its therapy OV101 (gaboxadol) in the treatment of Angelman syndrome, admitting that it failed …
News
88222

UK becomes first nation to approve Pfizer and BioNTech’s COVID-19 vaccine

December 2, 2020 Research and Development, Sales and Marketing COVID-19, Pfizer, UK, Vaccine

The UK has become the first country worldwide to authorise Pfizer and BioNTech’s promising COVID-19 vaccine, the UK Government has …
News
pharmafile_autumn_2020_front_cover

The Autumn 2020 edition of Pharmafile is available to read for free online now!

December 1, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing infectious diseases, pharmafile, rare disease, respiratory

The Autumn 2020 edition of Pharmafile is available to read for free online now! 2020 has seen almost unprecedented disruption …
News
shutterstock_273326141

Eisai and Wren Therapeutics join forces to tackle neurodegenerative synucleinopathies

December 1, 2020 Manufacturing and Production, Research and Development, Sales and Marketing Eisai, Wren Therapeutics

Eisai has forged an exclusive research partnership with Wren Therapeutics to develop new approaches in tackling neurodegenerative diseases known as …
News
avantor

Optimise your clinical trials with Avantor Clinical Services

December 1, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2020 Campaign, Avantor, clinical trials, expertise

Serious diseases like COVID-19 put increasing pressure on researchers to find breakthrough treatments faster. Along with accelerated timelines, biopharma and …
News
moderna_norwood_plant

Analysis confirms Moderna’s COVID-19 vaccine efficacy to be 94.1%

November 30, 2020 Research and Development, Sales and Marketing COVID-19, Moderna, Vaccine

US biotech Moderna has followed up on its highly promising efficacy data for its mRNA-based COVID-19 vaccine candidate with the …
News
lilly_building_with_american_flag_web

Canada secures 26,000 doses of Lilly therapy to treat COVID-19 in $32.5m deal

November 25, 2020 Manufacturing and Production, Research and Development COVID-19, Canada

The Canadian Government has partnered up with Eli Lilly to secure 26,000 doses of the company’s monoclonal antibody therapy bamlanivimab …
News
flu_vaccination_grippe_5115654021_5

Largest clinical trial treating mild to moderate COVID-19 patients to take place in Africa

November 25, 2020 Research and Development

The world’s largest clinical trial investigating the treatment of patients with mild to moderate COVID-19 is set to begin in …
News
1200px-eurotunnel_11

ABPI warns that no-deal Brexit could disrupt medicines and vaccine delivery

November 25, 2020 Research and Development

The Association of the British Pharmaceutical Industry (ABPI) has warned that the supplies of crucial medicines and vaccines could be …
News
1200px-oxycontin_branded_oxycodone_10mg_oc_side

Purdue Pharma pleads guilty to its role in the opioid crisis

November 25, 2020 Research and Development

Purdue Pharma has pleaded guilty to criminal charges over its role in fueling the opioid crisis which was driven by …
News
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

November 25, 2020 Research and Development

The coronavirus news this week sees more companies release their coronavirus vaccine results, with Pfizer and BioNTech backing up their …
News
pharmafocus_december_2020_cover

The December 2020 issue of Pharmafocus is available to read free online now!

November 24, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, clinical trials, diabetes, outsourcing

The final 2020 monthly edition of Pharmafocus is available to read for free online now! After a long and theatrical …
News
vaccination-1215279_960_720

Russia’s Sputnik COVID-19 vaccine has 91.4% efficacy after 28 days, new interim data show

November 24, 2020 Manufacturing and Production, Research and Development COVID-19, Sputnik V, Vaccine

The National Research Center for Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF) have released a statement saying …
News

Sanofi’s invasive meningococcal disease vaccine approved for EU use in four serotypes

November 23, 2020 Research and Development, Sales and Marketing

Sanofi’s MenQuadfi combination vaccine has secured approval from the European Commission for the prevention of invasive meningococcal disease caused by …
News
dado_ruvic-illustration-reuters

Interim analysis for AstraZeneca’s COVID-19 vaccine finds 70% average efficacy

November 23, 2020 Research and Development, Sales and Marketing AstraZeneca, COVID-19, Vaccine

Hot on the heels of Moderna and Pfizer/BioNTech who both have released very promising data for their mRNA COVID-19 vaccine …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025